Carl-Hendrik Heldin

Carl-Hendrik Heldin

Direktor/Vorstandsmitglied bei KANCERA AB

72 Jahre
Miscellaneous
Health Technology
Consumer Services

Ursprung des Netzwerks ersten Grades von Carl-Hendrik Heldin

EinheitArt der EinheitIndustrie
University of Uppsala
209
College/University Other Consumer Services 209
European Molecular Biology Organization
29
Non-Profit Organization 29
Public Company Pharmaceuticals: Major 16
The Nobel Foundation
6
Foundation/Endowment Investment Trusts/Mutual Funds 6
4
Private Company Miscellaneous Commercial Services 4

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von Carl-Hendrik Heldin

UnternehmenSektorVerknüpfte PersonenHauptposition
Karolinska Institutet College/University

Rolf Larsson

Hans Lennart Rudolf Wigzell

Charlotte Elisabet Edenius

Ulla Helena Danielson

Håkan Mellstedt

Margareta Elisabeth Björk

Anders Gabrielsen

Doctorate Degree

Chairman

Doctorate Degree

Corporate Officer/Principal

Corporate Officer/Principal

Doctorate Degree

Corporate Officer/Principal

Miscellaneous Commercial Services

Joseph P. Schlessinger

Erkki Ruoslahti

Paul Schulze Lefert

Antonio Lanzavecchia

Karen Vousden

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Royal Institute of Technology College/University

Karl Johan Anders Wall

Lars Ture Pettersson

Margot Gunilla Fransson

Martin Norin

Peter von Ehrenheim

Graduate Degree

Director/Board Member

Graduate Degree

Doctorate Degree

Graduate Degree

Q-LINEA AB Medical Specialties

Mats Bo Johan Nilsson Bernitz

Mats Gullberg

Jonas Sven Peter Jarvius

Johan Stenberg

Charlotta Göransson

Founder

Chief Tech/Sci/R&D Officer

Chief Executive Officer

Founder

Chief Tech/Sci/R&D Officer

University of Stockholm College/University

Hans-Peder Richter

Jonas Göran Ekblom

Mats Bo Johan Nilsson Bernitz

Johan Schultz

Undergraduate Degree

Undergraduate Degree

Corporate Officer/Principal

Doctorate Degree

MEDIVIR AB Pharmaceuticals: Major

Gustav Ingemar Kihlström

Charlotte Elisabet Edenius

Anders R. Hallberg

Bengt Westermark

Director/Board Member

Chief Tech/Sci/R&D Officer

Director/Board Member

Director/Board Member

Weizmann Institute of Science College/University

Joseph P. Schlessinger

Daniel L. Farkas

Ruth Arnon

Hermona Soreq

Doctorate Degree

Doctorate Degree

Corporate Officer/Principal

Doctorate Degree

The Hebrew University of Jerusalem College/University

Joseph P. Schlessinger

Ruth Arnon

Raymond Kaempfer

Hermona Soreq

Graduate Degree

Graduate Degree

Corporate Officer/Principal

Corporate Officer/Principal

Electronic Equipment/Instruments

Mats Bo Johan Nilsson Bernitz

Mats Gullberg

Jonas Sven Peter Jarvius

Johan Olof Kämpe

Founder

Founder

Founder

Director/Board Member

Miscellaneous Commercial Services

Gustav Ingemar Kihlström

Hans Lennart Rudolf Wigzell

Alf Gunnar Martin Nicklasson

Anders R. Hallberg

Director/Board Member

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

University of Cambridge College/University

David Glover

Ashok Venkitaraman

Michael Owen

Corporate Officer/Principal

Corporate Officer/Principal

Doctorate Degree

College/University

Robert Kamen

Raymond Kaempfer

Jamal Abisourour

Doctorate Degree

Corporate Officer/Principal

Graduate Degree

University of Helsinki College/University

J. Kenneth Charles Knowles

Erkki Ruoslahti

Hilpi Rautelin

Corporate Officer/Principal

Doctorate Degree

Corporate Officer/Principal

SPRINT BIOSCIENCE AB Pharmaceuticals: Major

Gustav Ingemar Kihlström

Claes Tomas Post

Ingemar Kihlström

Director/Board Member

Director/Board Member

Director/Board Member

Miscellaneous Commercial Services

Hans Lennart Rudolf Wigzell

Erkki Ruoslahti

Peter Ratcliffe

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Miscellaneous Commercial Services

Hans Lennart Rudolf Wigzell

Anders R. Hallberg

Bengt Westermark

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

KLARIA PHARMA HOLDING AB Pharmaceuticals: Major

Erik Kjellsson Nerpin

Hans-Peder Richter

Thomas Olin

Director/Board Member

Director of Finance/CFO

Director/Board Member

QUIAPEG PHARMACEUTICALS HOLDING AB Biotechnology

Marek Kwiatkowski

Mats Bo Johan Nilsson Bernitz

Jonas Sven Peter Jarvius

Corporate Officer/Principal

Director/Board Member

Director/Board Member

University of Lund College/University

Jan Thorell

Mathias Hallberg

Eva Ursula Hultqvist Bengtsson

Corporate Officer/Principal

Graduate Degree

Doctorate Degree

MEDCAP AB Medical Specialties

Gustav Ingemar Kihlström

Bengt Gerdin

Peter von Ehrenheim

Chairman

Director/Board Member

Chairman

Miscellaneous Commercial Services

David Glover

J. Kenneth Charles Knowles

Stephen Philip Jackson

Director/Board Member

Director/Board Member

Corporate Officer/Principal

Imperial College London College/University

David Glover

Johan Lindh

Alan Ashworth

Corporate Officer/Principal

Doctorate Degree

Undergraduate Degree

Miscellaneous Commercial Services

Stephen Philip Jackson

Alan Ashworth

Corporate Officer/Principal

Corporate Officer/Principal

Wholesale Distributors

Gustav Ingemar Kihlström

Claes Tomas Post

Corporate Officer/Principal

Chief Tech/Sci/R&D Officer

CREATIVE ANTIBIOTICS SWEDEN AB Pharmaceuticals: Major

Gustav Ingemar Kihlström

Bengt Gerdin

Chairman

Director/Board Member

IMMUNOCORE HOLDINGS PLC Biotechnology

J. Kenneth Charles Knowles

Peter Ratcliffe

Chief Executive Officer

Director/Board Member

Biotechnology

Hans-Peder Richter

Claes Tomas Post

Director of Finance/CFO

Director/Board Member

College/University

Lars Harald Baltzer

Claes Tomas Post

Corporate Officer/Principal

Corporate Officer/Principal

OxyPharma AB

Gustav Ingemar Kihlström

Bengt Gerdin

Director/Board Member

Director/Board Member

Miscellaneous Commercial Services

Joseph P. Schlessinger

Erkki Ruoslahti

Corporate Officer/Principal

Corporate Officer/Principal

Pharmaceuticals: Major

Charlotte Elisabet Edenius

Johan Lindh

Director/Board Member

Founder

BIOVICA INTERNATIONAL AB Biotechnology

Gustav Ingemar Kihlström

Marie-Louise Fjaellskog

Director/Board Member

Director/Board Member

OREXO AB Pharmaceuticals: Major

Alf Gunnar Martin Nicklasson

Charlotte Elisabet Edenius

Chairman

Chief Tech/Sci/R&D Officer

Blasieholmen Investment Group AB

Erik Kjellsson Nerpin

Thomas Olin

Director/Board Member

Director/Board Member

ZEALAND PHARMA A/S Pharmaceuticals: Major

Alf Gunnar Martin Nicklasson

Michael Owen

Chairman

Director/Board Member

Pharmaceuticals: Other

Alf Gunnar Martin Nicklasson

Jonas Göran Ekblom

Director/Board Member

Chairman

Marine Shipping

Lars Bohlin

Ulf Bertil Olof Göransson

Founder

Director/Board Member

SALTX TECHNOLOGY HOLDING AB Electronic Production Equipment

Erik Kjellsson Nerpin

Thomas Olin

Chairman

Chief Executive Officer

Miscellaneous Commercial Services

Alf Gunnar Martin Nicklasson

Jonas Rastad

Chief Executive Officer

Corporate Officer/Principal

NICOCCINO HOLDING AB Tobacco

Erik Kjellsson Nerpin

Hans-Peder Richter

Director/Board Member

Director of Finance/CFO

KARESSA PHARMA HOLDING AB (PUBL) Pharmaceuticals: Major

Erik Kjellsson Nerpin

Hans-Peder Richter

Chairman

Director of Finance/CFO

MIRIS HOLDING AB Electronic Equipment/Instruments

Gustav Ingemar Kihlström

Niklas Dahl

Chairman

Director/Board Member

VIVESTO AB Pharmaceuticals: Generic

Alf Gunnar Martin Nicklasson

Peter Selin

Director/Board Member

Corporate Officer/Principal

Statistik

International

Schweden 35
Vereinigte Staaten 6
Vereinigtes Königreich 6
Israel 3
Finnland 2

Sektoral

Health Technology 21
Consumer Services 12
Commercial Services 10
Electronic Technology 4
Distribution Services 2

Operativ

Director/Board Member 477
Corporate Officer/Principal 249
Chairman 119
Founder 83
Independent Dir/Board Member 81
  1. Börse
  2. Insiders
  3. Carl-Hendrik Heldin
  4. Unternehmensverbindungen
-40 % Zeitlich begrenztes Angebot: Unsere Abonnements führen Sie zu den besten Investitionen von morgen.
PROFITIEREN SIE JETZT